On Demand: Gastroenterology and Hepatology for Primary Care
|
$399.20
Use promo code (Limited Time Offer)
15 CREDITS
  Hurry! Offer expires January 1, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from the 2020 conferenceCourse Content
| Session | Title | Faculty |
| Session 1 (72 minutes) | Management of GERD: Balancing the Risk/Benefits of PPI Therapy | J. Pandolfino, MD |
| Session 2 (49 minutes) | Common Upper Gastrointestinal Symptoms: Dysphagia, Globus, Belching, Rumination/Vomiting | J. Pandolfino, MD |
| Session 3 (62 minutes) | Dyspepsia, Peptic Ulcer Disease and H. Pylori Infection | C. Howden, MD |
| Session 4 (47 minutes) | Pharmacology of Medicines Targeting Upper GI Disorders | C. Howden, MD |
| Session 5 (65 minutes) | Dietary Advice for UGI Conditions | S. Eswaran, MD |
| Session 6 (48 minutes) | Diagnosis and Management of Diarrhea | S. Hanauer, MD |
| Session 7 (70 minutes) | Inflammatory Bowel Disease (IBD) | S. Hanauer, MD |
| Session 8 (56 minutes) | Small Intestinal Issues Including Celiac Disease | A. Stein, MD |
| Session 9 (43 minutes) | Non-oral Nutrition: How to Manage Patients with TPN and a PEG Tube | A. Stein, MD |
| Session 10 (54 minutes) | Why Aren’t My Laxatives Working? Barking Up the Wrong Tree | D. Brenner, MD |
| Session 11 (78 minutes) | Irritable Bowel Syndrome: A Multidisciplinary Perspective | D. Brenner, MD & S. Quinton, PsyD |
| Session 12 (59 minutes) | Non-Alcoholic Fatty Liver Disease (NAFLD): The Essentials | B. Pearlman, MD |
| Session 13 (49 minutes) | Updates on Outpatient Hepatology Management | C. Moore, MD |
| Session 14 (41 minutes) | Evaluation of Abnormal Liver Function Tests | B. Pearlman, MD |
| Session 15 (39 minutes) | Update in Liver Transplant Management | C. Moore, MD |
| Session 16 (53 minutes) | Hepatology Case Studies | B. Pearlman, MD & C. Moore, MD |
Program Overview
Continuing Education Company has been organizing its Primary Care Conference Series for the past 27 years. These conferences are designed to update primary care clinicians in rapidly changing therapeutic areas. As part of this series, On Demand: Gastroenterology and Hepatology for Primary Care is an online course comprised of the recordings from the 2020 conference with an emphasis is on practical and useful information for clinical practice.
Gastrointestinal disorders are common in the general population. In the current health care arena, the primary care physician has increasingly assumed the role of primary care giver for patients with many of the most common gastrointestinal ailments. Consequently, it has become clinically important and economically prudent for primary care physicians to become familiar with the management of these disorders and perhaps most importantly when to consult a gastroenterologist. This program will address these evolving needs, providing the primary care provider with effective evidence-based diagnostic, therapeutic, and referral strategies for common gastrointestinal and liver related disorders.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Access and provide patients with an accurate diagnosis and optimal care for a broad range of gastrointestinal disorders seen in primary care.
- Integrate evidence-based strategies and recent guidelines for screening, prevention, and treatment of gastrointestinal disorders and their comorbidities in clinical practice.
- Formulate comprehensive evidence-based interventions and treatment strategies for gastrointestinal disorders that will lead to the reduction of modifiable risk factors and improved long-term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Division of Gastroenterology and Hepatology
Director of the Neurogastromotility and Functional Bowel Programs
Northwestern University Feinberg School of Medicine
Chicago, IL
Shanti Lynne Eswaran, MD
Clinical Associate Professor
Division of Gastroenterology
University of Michigan
Ann Arbor, MI
Stephen B. Hanauer, MD
Medical Director, Digestive Health Center
Northwestern Memorial Hospital
Professor of Medicine, Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Colin W. Howden, MD, FRCP, FACP, FACG, FCP
Hyman Professor of Medicine
Chief, Division of Gastroenterology
University of Tennessee College of Medicine
Memphis, TN
Christopher M. Moore, MD
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
John E. Pandolfino, MD (Conference Chairperson)
Division Chief, Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Brian L. Pearlman, MD, FACP, FAASLD, AAHIVS
Medical Director, Center for Hepatitis C, Wellstar Atlanta Medical Center
Professor of Medicine, Medical College of Georgia
Professor of Medicine, Emory School of Medicine
Atlanta, GA
Sarah E. Quinton, PsyD
Director, Behavioral Medicine for Digestive Health
Co-Director, Northwestern Integrated Bowel Dysfunction Program
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology and Psychiatry
Northwestern University Feinberg School of Medicine
Chicago, IL
Adam C. Stein, MD
Director of Nutrition Support
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 8 of which can be used towards Pharmacology, for completing this activity.
Release Date: 8/28/2020
Expiration Date: 8/28/2023 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosures |
| Darren Brenner, MD | Advisory Board, Consultant, Speakers Bureau: Allergan Pharmaceuticals, Ironwood, Salix, and Shire Advisory Board, Consultant: Alpha Sigma Advisory Board: Arena Pharmaceuticals |
| Shanti Eswaran, MD | Nothing to Disclose |
| Stephen B. Hanauer, MD | Clinical Research (Institution), Consultant, Speakers Bureau: AbbVie, Janssen, and Takeda Clinical Research (Institution), Consultant, Research Grant: Allergan Clinical Research (Institution), Consultant: Amgen, Celgene, Genentech, Lilly, Novartis, Pfizer, Prometheus, Receptos, and UCB Pharma Consultant, Data & Safety Monitoring Board: Arena and Bristol Myer Squibb Consultant: Celltrion, Gilead, GSK, Merck, Nestle, Progenity, Salix Samsun Bioepis, Seres Therapeutics, Tigenex, and VHsquared |
| Colin W. Howden, MD | Consultant: Alfasigma and RedHill Biopharma Stockholder: Antibe Advisory Board, Consultant: Ironwood and Phathom |
| Christopher Moore, MD | Nothing to Disclose |
| John E. Pandolfino, MD | Consultant: Ironwood Advisory Board, Consultant, Stockholder, Stock options w/ Crospon: Medtronic Advisory Board, Consultant, Speakers Bureau: Sandhill Speakers Bureau: Takeda Consultant, Speakers Bureau: Torax |
| Brian Pearlman, MD | Research Grant: Genfit and Novartis Research Grant, Speakers Bureau, Honoraria: Gilead Sciences |
| Sarah E. Quinton, PsyD | Research Grant: Pfizer Consultant: Takeda |
| Adam C. Stein, MD | Advisory Board, Speakers Bureau: AbbVie Speakers Bureau: Alcresta and Pfizer |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.